GI & Endoscopy

Janssen Biotech Earns FDA Approval for Ulcerative Colitis Treatment

Janssen Biotech, Horsham, Pa.-based branch of the Janssen Pharmaceutical Companies of Johnson & Johnson, has earned FDA approval for Simponi, its moderate to severe ulcerative colitis treatment, according to a Pharmabiz report.

Carrie Pallardy

Friday, May 17th, 2013

Simponi, a subcutaneously administered anti-tumor necrosis factor therapy, has shown to induce clinical remission in ulcerative colitis patients.

More Articles on Gastroenterology:
PENTAX Launches Video Processor With PENTAX i-SCAN
SAGES Appoints Dr. Gerald Fried President
AGA Receives $1.5M Research Grant From Takeda Pharmaceuticals

Next Up in GI & Endoscopy

FDA clears final trial stage for robotic GI surgery system

EndoQuest Robotics has received FDA approval to proceed with the final enrollment phase of its pivotal Paradigm trial evaluating a…

By: Sophie Eydis
2 days ago
Gastroenterologist pay breakdown in 10 stats

As of Dec. 14, gastroenterologists’ average annual salary is $583,380, according to salary transparency platform Marit Health’s compilation of 215…

By: Patsy Newitt
2 days ago
5 GI leaders on what’s changing in colonoscopy

Colonoscopy remains a cornerstone of colorectal cancer prevention, but GI leaders say the procedure’s role, and the business model built…

By: Patsy Newitt
2 days ago

Comments are closed.

Growth, mission + fragmentation: How academic health systems are confronting the next decade

Next Up in GI & Endoscopy

FDA clears final trial stage for robotic GI surgery system

Gastroenterologist pay breakdown in 10 stats

5 GI leaders on what’s changing in colonoscopy

Join the 40,000+ ASC leaders who start their day with Becker's